Clinical Research Directory
Browse clinical research sites, groups, and studies.
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Summary
This study will determine whether early, comprehensive, rhythm control therapy prevents adverse cardiovascular outcome in patients with acute ischemic stroke and atrial fibrillation compared to usual care.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1746
Start Date
2024-09
Completion Date
2029-03
Last Updated
2023-12-28
Healthy Volunteers
No
Conditions
Interventions
Medical or interventional therapy for rhythm control in atrial fibrillation (antiarrhythmic drugs, ablation, electric cardio version)
Therapy for early rhythm control will be either by use of approved antiarrhythmic drugs (e.g. amiodarone, dronedarone, flecainide, propafenone), approved approaches and devices for ablation, or electric cardio version.
Usual care for atrial fibrillation
Usual care for atrial fibrillation according to current guidelines. Usual care will mainly comprise rate control by approved drugs. We expect, that usual care will also comprise therapy for rhythm control in a small group of patients.